AYTU
AYTU BIOPHARMA, INC
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$1.90
−4.04%Margins
Gross margin
64.0%
EBITDA margin
-14.7%
EBIT margin
-14.4%
Net margin
-24.8%
FCF margin
5.6%
-40.4%
Return on equity
-13.6%
Return on assets
-15.6%
Return on invested capital
0.53x
Asset turnover
$3.3M
Cash from operations
$2.42
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026